Answers are grounded in this paper and cite their sources.
< 0.0001), while Bland-Altman analysis indicated a bias of 0.26 INR units. The presence of antiphospholipid antibodies appears to interfere with PT/INR measurements obtained by the bSens.INR, reducing accuracy in APS and SLE patients. Although the device shows promising performance, its use in autoimmune populations should be approached with caution, reinforcing previous findings on the limitations of RLT in these conditions.
No takes yet. Share an insight, caveat, or question.
Jantzch et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: